<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00095368</url>
  </required_header>
  <id_info>
    <org_study_id>111.301</org_study_id>
    <nct_id>NCT00095368</nct_id>
  </id_info>
  <brief_title>APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat</brief_title>
  <official_title>A Phase III, Randomized, Double-Blind, Double-Dummy Multicenter Study to Evaluate the Efficacy and Safety of 775 mg APC-111 MP Tablet QD for 7 Days vs Penicillin VK 250 mg QID for 10 Days in Patients With Streptococcus Pyogenes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advancis Pharmaceutical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advancis Pharmaceutical Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of the this study is to evaluate the safety of efficacy of APC-111 775 mg MP
      tablet once daily dosing for 7 days for treating patients with strep throat. The evaluation
      will look to confirm if APC-111 eliminates the bacterial infection (Streptococcus pyogenes).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date>May 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bacteriological outcome at the Test of Cure Visit</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacteriological outcome at the Late Post Therapy Visit</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
  </secondary_outcome>
  <enrollment>500</enrollment>
  <condition>Pharyngitis</condition>
  <condition>Tonsillitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin Pulsatile Release Multiparticulate Tablet (drug)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Give informed consent, assent and patient authorization

          -  Age 12 and over

          -  A clinical diagnosis of acute pharyngitis or tonsillitis

          -  A positive rapid Strep test

          -  Can swallow the oral study dosage forms

          -  Females must have a negative urine pregnancy test and be using acceptable birth
             control if sexually active

        Exclusion Criteria:

          -  Chronic or recurrent odynophagia

          -  Need for hospitalization or IV antimicrobial therapy

          -  Pharyngitis known or suspected due to a pathogen resistant to beta-lactam
             antimicrobials

          -  Known carrier of S. pyogenes

          -  Allergies to penicillin or other beta-lactam antibiotics

          -  Any serious illness or concomitant condition that the investigator judges will
             preclude inclusion to the study

          -  Seizure disorder

          -  Pregnant or nursing

          -  Expectation of additional systemic antibacterials would be required for another
             condition

          -  Current drug or alcohol abuse

          -  Any experimental drug or device within the last 30 days

          -  Prior systemic antibiotic therapy within the last 30 days

          -  Hospitalization within the last month which included antibacterial therapy

          -  The presence of clinically significant hematologic conditions, etc

          -  Probenecid treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Manford Gooch, MD</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2004</study_first_submitted>
  <study_first_submitted_qc>November 3, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2004</study_first_posted>
  <last_update_submitted>December 6, 2006</last_update_submitted>
  <last_update_submitted_qc>December 6, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2006</last_update_posted>
  <keyword>Pharyngitis</keyword>
  <keyword>Tonsillitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Penicillins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

